Top Markets
Coin of the day
Creso Pharma Limited Creso Pharma Limited

Creso Pharma Limited

CPH
Clasificación en acciones #30562
Creso Pharma Ltd. specializes in the development, registration, and... Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific. The company also undertakes the creation and sale of therapeutic products, in addition to cultivating, processing, and supplying cannabis products to retail markets. Among its diverse product line are "anibidiol," a complementary feed for companion animals; "cannaQIX," a nutraceutical containing hemp oil extract, vitamins, and zinc, formulated to reduce stress and support psychological and nervous system functions; and topical skincare items like "cannaDOL," a CBD-based gel featuring a blend of cooling and warming essential oils. Creso Pharma Limited was founded in 2015 and operates from its headquarters in Nedlands, Australia.
Precio por acción
$0.00634756
Última sincronización: 2023-06-09
Capitalización bursátil
$16.30M
Cambio (1 día)
5.01%
Cambio (1 año)
0.00%
País
AU
Comercio Creso Pharma Limited (CPH)

Categoría

Ratio P/S de Creso Pharma Limited (CPH)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Creso Pharma Limited, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Creso Pharma Limited desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras